Oncology Institute【TOI】株式ニュース

名称	銘柄コード	市場	種別
Oncology Institute Inc	TOI	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0096	-1.50%	0.6294	06:42:26

始値	安値	高値	終値	前日終値
0.62	0.60	0.639	0.61	0.639

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/15	05:05	GLOBE	The Oncology Institute Reports First Quarter 2024 Financial..
2024/5/08	05:05	GLOBE	The Oncology Institute to Participate in Panel Discussion at..
2024/4/23	21:00	GLOBE	The Oncology Institute Announces First Quarter 2024 Earnings..
2024/4/08	21:00	GLOBE	Jordan McInerney Appointed as Chief Development Officer of..
2024/4/04	21:00	GLOBE	The Oncology Institute and Healthly Forge Strategic Alliance..
2024/3/28	05:05	GLOBE	The Oncology Institute Reports Fourth Quarter and Full Year..
2024/3/14	21:09	GLOBE	MaxHealth & The Oncology Institute Expand Value-Based Care..
2024/3/06	22:00	GLOBE	The Oncology Institute Announces Fourth Quarter and Full..
2024/2/28	06:05	GLOBE	The Oncology Institute to Participate at Upcoming Investor..
2024/2/20	22:00	GLOBE	Carrum Health and The Oncology Institute Partner on Breast..
2024/1/25	22:00	GLOBE	WellBe Senior Medical Partners with The Oncology Institute..
2024/1/20	06:00	EDGAR2	Form 144 - Report of proposed sale of securities
2023/12/29	07:46	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/29	07:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/29	07:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/05	09:42	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/04	22:00	GLOBE	The Oncology Institute Expands its Specialty Medication..
2023/11/23	11:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/23	10:47	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/23	10:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/22	09:27	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/18	07:27	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/17	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/17	05:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/16	08:49	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/14	07:17	EDGAR2	Form 144 - Report of proposed sale of securities
2023/11/09	06:43	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09	06:41	EDGAR2	Form 8-K - Current report
2023/11/09	06:05	GLOBE	The Oncology Institute Reports Third Quarter 2023 Financial..
2023/10/18	21:03	GLOBE	The Oncology Institute Announces Third Quarter 2023 Earnings..
2023/10/12	05:05	GLOBE	The Oncology Institute Names Jeremy Castle as Chief..
2023/9/27	05:05	GLOBE	The Oncology Institute Executive Leaders to Present at the..
2023/9/18	21:00	EDGAR2	Form 8-K - Current report
2023/9/18	21:00	GLOBE	The Oncology Institute Regains Compliance with Nasdaq..
2023/9/08	03:36	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2023/9/07	05:07	EDGAR2	Form 8-K - Current report
2023/9/02	05:00	EDGAR2	Form 8-K - Current report
2023/8/31	04:04	EDGAR2	Form 8-K - Current report
2023/8/11	06:15	EDGAR2	Form 8-K - Current report
2023/8/10	05:27	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/09	21:10	GLOBE	Ambience Healthcare and The Oncology Institute (TOI) Partner..
2023/8/09	05:40	GLOBE	The Oncology Institute Reports Second Quarter 2023 Financial..
2023/7/31	21:00	GLOBE	The Oncology Institute Partners with House Rx to Accelerate..
2023/7/18	21:00	GLOBE	The Oncology Institute Announces Second Quarter 2023..
2023/6/12	19:00	GLOBE	The Oncology Institute Announces Leadership Transition
2023/6/09	21:00	GLOBE	The Oncology Institute (TOI) and Massive Bio Forge..
2023/6/07	21:00	GLOBE	The Oncology Institute to Open Project Southland
2023/5/31	21:01	GLOBE	The Oncology Institute Featured on Four Abstracts at ASCO..
2023/5/31	21:00	GLOBE	The Oncology Institute to Participate at Upcoming Investor..